Imidiazo -and triazolopyridines as inhibitors of 11-beta hydroxysteroid dehydrogenase type I

Details for Australian Patent Application No. 2006258077 (hide)

Owner Bristol-Myers Squibb Company

Inventors Hamann, Lawrence G.; Wang, Haixia; Li, James J.

Agent A J Park

Pub. Number AU-B-2006258077

PCT Pub. Number WO2006/135667

Priority 11/448,946 07.06.06 US; 60/688,993 09.06.05 US

Filing date 8 June 2006

Wipo publication date 21 December 2006

Acceptance publication date 23 February 2012

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

Event Publications

6 December 2007 PCT application entered the National Phase

  PCT publication WO2006/135667 Priority application(s): WO2006/135667

23 February 2012 Application Accepted

  Published as AU-B-2006258077

21 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006258078-Inter-blade guard and method for manufacturing same

2006258066-Processes for the preparation of paclitaxel